过度表达TRPM8抑制肝细胞癌的进展,并通过调节RTP3/STAT3通路来改善存活率
Lichan Chen1, Nansong Xu2, DongMei Gou3
1Department of Laboratory Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital; Shenzhen Key Laboratory of Medical Laboratory and Molecular Diagnostics; Guangzhou Medical University, Shenzhen, China.
在肝细胞癌 (HCC) 中,TRPM8 (过时受体潜在梅拉斯塔丁8) 作为瘤抑制剂起作用. 降低TRPM8表达与预后不佳相关,其上调抑制了通过RTP3/STAT3通路的HCC进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 肝细胞癌 (HCC) 给全球健康带来了重大挑战.
- TRPM8在HCC进展中的作用尚未完全理解.
- 研究TRPM8为新的治疗策略提供了潜力.
研究的目的:
- 在HCC中探索TRPM8表达水平.
- 阐明TRPM8在HCC中的分子功能和机制.
- 评估TRPM8.的诊断和预后价值.
主要方法:
- 在HCC组织样本中分析TRPM8表达.
- 在体外测试 (细胞计数套件-8,EDU,殖民地形成,Transwell) 来评估扩散,迁移和入侵.
- 使用老鼠异种移植模型进行体内研究.
- 蛋白质与蛋白质相互作用 (PPI) 网络分析,以获得机制性见解.
主要成果:
- 在HCC组织中,TRPM8的表达下调,与较高的组织学等级和较差的患者预后相关.
- 在体外和体内,TRPM8显著抑制HCC细胞的增殖和转移.
- TRPM8-RTP3-STAT3信号通路调解这些抗瘤作用.
结论:
- TRPM8-RTP3-STAT3轴在调节HCC恶性进展方面至关重要.
- 提高TRPM8表达,可能通过AD80等药物,显示出抗瘤活性.
- TRPM8作为HCC的潜在治疗点.
更多相关视频
09:01Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
